|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/16/22 Novo Integrated Sciences, Inc. 8-K:8,9 3/16/22 11:223K M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: 8-K Current Report HTML 27K
2: EX-99.1 Miscellaneous Exhibit HTML 16K
6: R1 Cover HTML 48K
9: XML IDEA XML File -- Filing Summary XML 12K
7: XML XBRL Instance -- form8-k_htm XML 15K
8: EXCEL IDEA Workbook of Financial Reports XLSX 6K
4: EX-101.LAB Inline XBRL Taxonomy Extension Label Linkbase XML 97K
Document -- nvos-20220316_lab
5: EX-101.PRE Inline XBRL Taxonomy Extension Presentation XML 64K
Linkbase Document -- nvos-20220316_pre
3: EX-101.SCH Inline XBRL Taxonomy Extension Schema Document -- XSD 13K
nvos-20220316
10: JSON XBRL Instance as JSON Data -- MetaLinks 25± 33K
11: ZIP XBRL Zipped Folder -- 0001493152-22-006938-xbrl Zip 14K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest reported): i March 16, 2022
i Novo Integrated Sciences, Inc.
(Exact name of registrant as specified in its charter)
| i Nevada | i 001-40089 | i 59-3691650 | ||
| (State or other jurisdiction | (Commission | (IRS Employer | ||
| of Incorporation) | File Number) | Identification Number) |
i 11120 NE 2nd Street, i Suite 100, i Bellevue, i WA i 98004
(Address of principal executive offices)
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol(s) | Name of Each Exchange on which Registered | ||
| i Common Stock, $0.001 par value | i NVOS | i The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
C:
Item 8.01. Other Events.
On March 16, 2022, Novo Integrated Sciences, Inc. (the “Company”) issued a press release announcing that Robert Mattacchione, the Company’s Chief Executive Officer and Board Chairman, will present at the Maxim Group 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28-30, 2022.
A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description | |
| 99.1 | Press release issued by the registrant on March 16, 2022. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
C:
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Novo Integrated Sciences, Inc. | ||
| Dated: March 16, 2022 | By: | /s/ Robert Mattacchione |
| Robert Mattacchione | ||
| Chief Executive Officer | ||
C:
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / For Period end: | 3/16/22 | None on these Dates | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/14/22 Novo Integrated Sciences, Inc. 424B4 1:3.7M M2 Compliance LLC/FA 10/07/22 Novo Integrated Sciences, Inc. S-1/A 105:18M M2 Compliance LLC/FA 9/13/22 Novo Integrated Sciences, Inc. S-1 101:17M M2 Compliance LLC/FA |